Phillis John W, O'Regan Michael H
Department of Physiology, School of Medicine, Wayne State University, 5374 Scott Hall, 540 East Canfield, Detroit MI 4801, USA.
Eur J Pharmacol. 2003 Aug 29;476(3):211-9. doi: 10.1016/s0014-2999(03)02187-3.
The role of adenosine in the cerebrovascular response to carbon dioxide inhalation was evaluated in two sets of experiments. The pial circulation was recorded by a Laser-Doppler flow probe placed over a closed cranial window in methoxyflurane anesthetized rats. Topical application of the nonselective adenosine receptor antagonist caffeine (1 mM), the selective A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX,1 microM), or the selective A2A receptor antagonist 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a]triazin-5-yl amino]ethyl) phenol (ZM 241385, 1 microM) all failed to affect mean arterial blood pressure, basal cerebral blood flow, or the carbon dioxide-evoked hyperemia. Systemically administered caffeine (20 mg/kg) also had no significant effects. However, following the systemic administration of the nonselective nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 20 mg/kg), the topical application of both caffeine and ZM 241385 (but not DPCPX) significantly reduced the carbon dioxide-evoked hyperemia. L-NAME (20 mg/kg) administered intravenously, evoked a significant increase in mean arterial blood pressure, a slow progressive decline in cerebral blood flow and, during brief (60-90 s) periods of 7.5% carbon dioxide inhalation, a significant decrease in arterial blood pressure. L-NAME failed to reduce the carbon dioxide-evoked increase in cerebral blood flow as measured by the area under the curve (AUC), although it did reduce the peak flow response. Topically applied L-NAME (1 mM) failed to alter mean arterial blood pressure, basal cerebral blood flow, or the carbon dioxide-evoked increases in cerebral blood flow. In a second series of experiments, we evaluated the ability of 10% carbon dioxide inhalation for 8 min to elicit a release of adenosine from the cerebral cortex. Adenosine levels in the cortical superfusates rose significantly during periods of carbon dioxide inhalation. The data suggest that following the removal of the confounding effects of nitric oxide, which are unlikely to be mediated locally, a significant contribution by adenosine A2A receptor activation to the carbon dioxide-evoked cortical hyperemia was evident.
在两组实验中评估了腺苷在脑血管对吸入二氧化碳反应中的作用。在甲氧氟烷麻醉的大鼠中,通过置于封闭颅窗上方的激光多普勒血流探头记录软脑膜循环。局部应用非选择性腺苷受体拮抗剂咖啡因(1 mM)、选择性A1受体拮抗剂8-环戊基-1,3-二丙基黄嘌呤(DPCPX,1 μM)或选择性A2A受体拮抗剂4-(2-[7-氨基-2-(2-呋喃基)[1,2,4]三唑并[2,3-a]三嗪-5-基氨基]乙基)苯酚(ZM 241385,1 μM)均未能影响平均动脉血压、基础脑血流量或二氧化碳诱发的充血。全身给予咖啡因(20 mg/kg)也无显著影响。然而,在全身给予非选择性一氧化氮合酶抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME,20 mg/kg)后,局部应用咖啡因和ZM 241385(但不是DPCPX)均显著降低了二氧化碳诱发的充血。静脉注射L-NAME(20 mg/kg)可使平均动脉血压显著升高,脑血流量缓慢进行性下降,并且在短暂(60 - 90秒)吸入7.5%二氧化碳期间,动脉血压显著降低。尽管L-NAME确实降低了峰值血流反应,但未能通过曲线下面积(AUC)测量降低二氧化碳诱发的脑血流量增加。局部应用L-NAME(1 mM)未能改变平均动脉血压、基础脑血流量或二氧化碳诱发的脑血流量增加。在第二系列实验中,我们评估了吸入10%二氧化碳8分钟引发大脑皮质释放腺苷的能力。在吸入二氧化碳期间,皮质灌流液中的腺苷水平显著升高。数据表明,在消除一氧化氮的混杂效应(不太可能由局部介导)后,腺苷A2A受体激活对二氧化碳诱发的皮质充血有显著贡献是明显的。